The Uromigos Episode 173: The ATLANTIS Trial—Maintenance Cabozantinib

By The Uromigos - Last Updated: November 11, 2022

Robert Jones, MD, talks about the hypothesis for ATLANTIS, its specific trial results, and more. The data was presented at ASCO 2022.

Post Tags:Uromigos-ASCO

Related Podcasts

Episode 398: Reflections on the Felix Feng Symposium at ASCO GU

Episode 397: APCCC Diagnostics Conference Recap

Uromigos-Prostate Cancer

Episode 394: APCCC (Advanced Prostate Cancer Consensus Conference) Diagnostics 2025

Uromigos-Prostate Cancer

Episode 393: ASCO GU 2025 Review Podcast

Episode 392: ASCO GU 2025 - HIF Inhibition With Casdatifan in Refractory RCC

Uromigos-Kidney Cancer